Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Caliway Biopharmaceuticals Co. L
No Price
Closing Price XTAI 30.04.2026:
104,00 TWD
30.04.2026 05:30
Current Prices from Caliway Biopharmaceuticals Co. L
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
TWSE
6919.TW
TWD
30.04.2026 05:30
104,00 TWD
-
Share Float & Liquidity
Free Float73,77 %
Shares Float1,15 B
Shares Outstanding1,56 B
Company Profile for Caliway Biopharmaceuticals Co. L Share
Caliway Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the development of drugs for aesthetic medicine and chronic inflammation. The company develops CBL-514, an investigational drug, which is in Phase 2 clinical trial for non-surgical fat reduction and Dercum's disease, as well as for cellulite treatment. It is also developing CBA-539, which is in preclinical stage for central obesity, hyperpigmentation, and skin aging, as well as offers dietary supplements. The company was incorporated in 2012 and is based in New Taipei City, Taiwan.
